All roads lead to Mullingar for the weekend 17/18 May when clubs from all over Ireland, from Belfast to Blarney, and from ...

Canon announced the new imagePROGRAF TC-21, successor to the imagePROGRAF TC-20 compact desktop large format printer. As a ...

Nerandomilast significantly slowed lung function decline in patients with IPF, with the 18 mg dose showing a 68.8 mL FVC decline reduction compared with placebo. The trial included 1177 patients ...

Boehringer Ingelheim announced today detailed findings from the Phase III FIBRONEER™-IPF and FIBRONEER™-ILD trials. These studies evaluated nerandomilast, an investigational oral, preferential ...

Current idiopathic pulmonary fibrosis (IPF) trials often exclude diverse patient perspectives, leading to unrepresentative conclusions and limited patient engagement. Issues identified include ...

Research conducted in collaboration with IPF experts and the Pulmonary Fibrosis Foundation reveals critical gaps in diagnosis, treatment, and quality of life for people living with IPF Findings ...

Now, Canon has jumped back into compacts with the PowerShot V1, a vlogging-centric model that follows the six-year-old G7X Mark III. It’s designed to outshine rivals with a large 1.4-inch 22 ...

Boehringer revealed the study, which tested the PDE4B inhibitor in idiopathic pulmonary fibrosis (IPF), met its primary endpoint in September. The update ended the long wait for a molecule capable ...

“After a decade of failed phase 3 trials, we have now a positive trial, which is really important to the treatment of people with IPF.” In the multicenter, double-blind, randomized, placebo ...

Its pipeline is currently headed by VP01 (also known as C21), billed as a first-in-class oral angiotensin II type 2 receptor (AT2R) agonist, which is in phase 2 development for IPF and phase 3 for ...